BioUtah News
-
The Point Kick Off
On Monday, government leaders, including Lt. Governor Spencer Cox, held a press conference announcing the launch of planning…
-
RenalytixAI Reaches Milestone of KidneyIntelX Commercial Testing with Mount Sinai Health System
Salt Lake City-based RenalytixAI, today announced the commercial launch of the KidneyIntelX clinical test reporting platform within the…
-
Clene Nanomedicine, Inc. Completes Enrollment in Rescue-ALS Clinical Trial for Treatment of Amyotrophic Lateral Sclerosis (ALS) with Lead Nanocatalytic Therapeutic, CNM-Au8
Clene Nanomedicine, Inc., (“Clene”) a clinical-stage biopharmaceutical company and its Australian subsidiary, Clene Australia Pty Ltd., on Tuesday…
-
Inherent Biosciences Wins $256K NSF Grant to predict COVID-19 infection severity and treatment response
Inherent Biosciences, a biotechnology company headquartered in Salt Lake City has announced a $255,959 award from the National…
-
BioUtah Statement on Launch of Altitude Lab, Largest Life Sciences Incubator in Utah
Recursion and University of Utah found incubator to propel new generation of life sciences in the region August…
-
At White House Roundtable, CSL Behring CEO Paul Perreault Urges Plasma Donations to Fight COVID-19
At a July 30 White House Roundtable, plasma industry leader and CSL Behring (CSL) CEO Paul Perreault, urged…
-
Utah Kidney Diagnostics Company Renalytix AI Announces IPO
Exciting news comes our way this week with the announcement by BioUtah member, Renalytix AI (Renalytix), that the…
-
Utah COVID-19 Relief Programs Go Live
Last week, BioUtah News and Events, reported that a number of new grant programs established by the Utah…
-
Recap of Stock Market Update with Monica DiCenso of JP Morgan
After leaving quite an impression to the attendees of the 2020 Entrepreneur and Investor Summit, we brought Monica…
-
BioUtah Joins ‘InUtah’ Campaign
The recently launched statewide ‘In Utah’ campaign encourages protecting public health and economic reactivation as we continue to…
-
New Utah COVID-19 Economic Relief Programs Take Shape
New and improved grant programs, aimed at providing economic support to Utah businesses impacted by COVID-19, are being…
-
BioFire Respiratory Panel with COVID Target Scores CE Mark
BioMerieux announced that Utah-based BioFire’s Respiratory Panel 2.1 plus, which tests for SARS-CoV-2 and 23 pathogens encompassing 19…
-
PhotoPharmics Stay-At-Home Trial for People with Parkinson’s
This week, PhotoPharmics announced a collaboration with the Center for Health + Technology (CHeT) at the University of…
-
Johnson & Johnson to Begin COVID-19 Vaccine Clinical Trials in Humans Next Week
Last month, Johnson & Johnson (J&J) announced that its Phase 1/2a in-human clinical trial of its potential COVID-19…
-
Pfizer, BioNTech Get FDA Fast Track Status for COVID-19 Vaccines
U.S. Pfizer and Germany’s BioNTech announced Monday that they have received Fast Track designation from the FDA for…
-
Alucent Biomedical Announces First Patient Enrolled in Phase 1 Natural Vascular Scaffolding Clinical Trial
Multicenter ACTIVATE I Study to Enroll up to 15 Patients in the U.S. SALT LAKE CITY – May…
-
BioUtah Mourns Loss of Soft Cell Founder and CEO, John “Brent” Hunt
BioUtah and Utah’s life sciences community mourns the death of one our own, John “Brent” Hunt, age 59. …
-
Utah’s Control Medical Technology Gets FDA Clearance for New Mechanical Thrombectomy Platform
Control Medical Technology announced on May 7 that the FDA cleared the company’s Control 7 – 11F Mechanical…
-
IDbyDNA Participates in NIH National COVID-19 Genomics Consortium
The CDC is leading the national SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance initiative (SPHERES)…
-
Silver lining: opportunities can arise from the corona crisis
Author: Anja Petschauer Co-authors: Anna Derschang, Melitta Gilllespie gwSaar has been a member of BioUtah and a trusted partner…
-
BioUtah’s Newest Associate Member: Greg Gunn, Colliers International
BioUtah’s newest Associate Member is Greg Gunn at Colliers International. With over 35 years of experience in commercial…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8M Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial…
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
